People

Smart & Biggar is Canada’s largest and highest ranked intellectual property firm. Our reputation and strength is a measure of the quality of our people, and we are proud to have the broadest and deepest bench for IP in Canada. With over 180 lawyers, patent agents and trademark agents, we offer legal expertise and technological knowledge across a wide range of industries and scientific and engineering disciplines, with leaders in every field.

Services

Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP. Our highly skilled team of lawyers, patent agents and trademark agents advise clients on a wide variety of strategic business, brand and technology matters leveraging their deep expertise in intellectual property to help them succeed with IP.

Industries

Across all industries, intellectual property is at the heart of innovation and is key to accelerating business value and growth. Developing a clear IP strategy and knowing how to tap and leverage IP to align with business goals can unlock competitive advantages and make the difference between industry leaders and followers.

Insights

At the forefront of IP in Canada, and actively involved as leaders in industry committees and associations, we stay up-to-date and proactively report on the latest developments in intellectual property law in Canada and around the world. Breaking IP news, changes in the law, important new decisions, and information on key IP issues are provided here through our IP publications and resources.

Careers

Many of the world's most commercially important innovators and most prominent brands trust Smart & Biggar to protect and enforce their IP and to provide them with strategic IP counsel. We have developed a reputation as a firm of talented lawyers and patent and trademark agents with integrity, business savvy and tremendous acumen. That’s why we look for the brightest people with combined talent and strengths in law, business, science and technology.

Who we are

Smart & Biggar is widely recognized as Canada’s leading firm for intellectual property, and with over 180 lawyers, patent agents and trademark agents in six offices, we are also Canada’s largest firm focused purely on IP and related specialty areas.

Case

Instituto Dos Vinhos Do Douro e Do Porto, I.P. v SALENTEIN ARGENTINA B.V.

2024 TMOB 225

Brigitte Chan and William Audet

December 27, 2024

Successfully opposed a trademark application for PORTILLO on the ground that the mark is deceptively misdescriptive.

Related People

William Audet
- he/him/his
Associate
- Smart & Biggar LP
- T:514.871.2931
- waudet@smartbiggar.ca
- Montréal
William Audet
Associate
William’s practice focuses on trademark and copyright protection, including intellectual property litigation, as well as clearance, prosecution, trademark oppositions and cancellations, availability o...
Read More
Brigitte Chan
- she/her/hers
Principal
- Smart & Biggar LP
- T:514.871.2920
- bchan@smartbiggar.ca
- Montréal
Brigitte Chan
Principal
Brigitte provides legal and strategic advice to domestic and international clients on trademark prosecution, opposition, licensing and enforcement, as well as on industrial design, copyright, related ...
Read More

Client Success

Nova Chemicals Corporation v Dow Chemical Company
2022 SCC 43
Jeremy Want, Daniel Davies, Matthew Burt and Nicole Boyle
November 18, 2022
Smart & Biggar successfully represented Dow Chemical before the Supreme Court of Canada, affirming the largest reported Canadian patent infringement award in history including the first time that ...
Read More
Tekna Plasma Systems Inc v AP&C Advanced Powders & Coatings Inc
2024 FC 871
Jean-Sébastien Dupont, François Guay, Jeremy Want and Audrey Berteau
June 07, 2024
Smart & Biggar successfully represented Tekna Plasma Systems (Tekna), the plaintiff in this action.
Read More
Boehringer Ingelheim (Canada) Ltd v Jamp Pharma Corporation
2024 FC 1198
Sheldon Hamilton, Nancy Pei, Urszula Wojtyra, Lynn Ing and Chen Li
August 08, 2024
Smart & Biggar successfully represented Boehringer Ingelheim in a s. 6(1) action under the Patented Medicines (Notice of Compliance) Regulations regarding the use of nintedanib in the prevention o...
Read More

People

Search People